The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Molecular Medicine
PreviousPrevious
Volume 334:1185-1187 May 2, 1996 Number 18
NextNext

Adenoviruses as Gene-Delivery Vehicles

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
For gene therapy to realize its clinical potential, there must be efficient and safe strategies of delivering therapeutic genes to somatic cells in vivo. Perhaps this problem simply represents a special case of drug delivery in which the therapeutic gene constitutes the drug. But the relevance of traditional drug development to technological developments in gene therapy is questionable. Recombinant genes that can independently express a therapeutic RNA or protein are extraordinarily large and polar molecules — 10,000 times larger than traditional pharmaceutical agents. Moreover, the administration of genes as therapy requires vehicles —so-called vectors — that encapsulate the gene and . . . [Full Text of this Article]


Source Information

From the Institute for Human Gene Therapy and the Department of Molecular and Cellular Engineering, University of Pennsylvania, and the Wistar Institute -- both in Philadelphia.

Address reprint requests to Dr. Wilson at the Institute for Human Gene Therapy, 204 Wistar Institute, 3601 Spruce St., Philadelphia, PA 19104-4268.

Recommended Reading


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.